Prof John Breitner, Professor of Psychiatry at McGill University.

Om avsnittet

Why clinical trials fail to validate efficacy of interventions predicted by observational studies of ‘risks’ for dementia-Alzheimer syndrome?, Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis, and Cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology

Prof John Breitner is Professor of Psychiatry at McGill University. He is also Director of the Centre for Studies on Prevention of Alzheimer’s Disease at the Douglas Research Centre

Om avsnittet

Fler avsnitt

Prof. Alex Chan of Harvard on Explainable AI, Medical liability of AI, and the collapse of WWW.

Prof. Zaldy Tan of UCLA on What to Remember When You Are Forgetting

Prof. Mark Mattson of Johns Hopkins on metabolic switching and intermittent fasting

Prof. Rachael Brown of the University of Chicago on Christians and Christianity

Prof. Trevor Robbins of Univ. of Cambridge on the neural basis of compulsive disorders

Prof. Eric Betzig of Univ. of California, Berkely on high resolution imaging of biological systems

Prof. Emil Martinec of the University of Chicago on String theory & black holes information paradox

Prof. Jonathan Silvertown of the Univ. of Edinburgh on how leaves conjure up the world

Prof. Stephanie Schmitt-Grohe of Columbia University on the Neo-Fisher Effect in Monetary Policy

Prof. Mariassunta Giannetti on supply chains, market power, inflation and liquidity reallocation